Overview

Glutaminergic Agents for Cocaine Abuse - 5

Status:
Completed
Trial end date:
1999-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Treatments:
Cocaine
Nimodipine